Every product we track, and where each one stands.

FDA-cleared mammography (DBT), chest X-ray, and CT algorithms with published detection-performance studies and broad international deployment.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +1 more reason on the product page.

Nabla Copilot is an ambient AI clinical documentation assistant that listens to patient encounters and generates structured notes in seconds, alongside real-time at-cursor dictation and coding suggestions across 35+ languages. It deploys via direct EHR integrations or the Nabla Connect iFrame for API-less systems, and is evolving into an agentic platform for broader clinical workflows.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +1 more reason on the product page.

Agentic AI workforce for patient intake, registration, scheduling, and authorization across digital front doors; deep Epic integration.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +4 more reasons on the product page.

AI-powered clinical evidence synthesis for physicians, grounded in the medical literature (NEJM/JAMA corpus partnerships), free to verified US clinicians; fastest clinician adoption curve of any CDS startup on record.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +2 more reasons on the product page.

Enterprise agentic AI platform spanning the full revenue cycle via three flagship products: Phare Access (patient access and authorization), Phare Claim (autonomous inpatient coding/CDI), and Phare Flow (autonomous claim follow-up, denials, and appeals). R1 reports Phare Claim autonomous coding accuracy as high as 97% for select service lines and Phare Flow already automating more than 20% of payer documentation requests by dollar volume.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +4 more reasons on the product page.

Patient activation platform covering digital intake, registration, scheduling, payments and outreach that facilitated ~170M patient visits in 2024 (1 in 7 U.S. visits). VoiceAI, launched September 2025, adds conversational AI call management that triages and routes inbound calls 24/7 without phone trees.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +4 more reasons on the product page.

AI chest X-ray interpretation suite that detects, localizes and quantifies 30+ findings (lung nodules, tuberculosis, pneumothorax, pleural effusion, cardiomegaly) to support radiologists, ER physicians and population screening programs. Includes qXR-Detect, the only FDA-cleared chest X-ray CADe with a Predetermined Change Control Plan, part of 26 FDA-cleared indications across 9 products.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +2 more reasons on the product page.

AI-based care operations automation platform that deploys autonomous 'AI teammates' across inpatient capacity, perioperative care coordination, surgical growth, and care gap/coding workflows, predicting bottlenecks and taking action inside EHR workflows rather than just surfacing insights. Includes an AI Solution Factory co-development model for health systems to build custom AI Operational Assistants, leveraged by 150+ hospital facilities with a claimed average 11x ROI.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +5 more reasons on the product page.

Stroke and vascular imaging AI (CTP/CTA analysis) with the largest published stroke-imaging evidence base and hospital network deployment for stroke-system coordination.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +1 more reason on the product page.

Voice-first AI assistant for clinical documentation with ambient mode, dictation, and command features; EHR-writeback across major platforms and an SDK for embedding scribe capability into other health IT products.

Profile and sourced claims are available, but the evidence does not currently support a ranking. Does not pass the documentary gate on current or aging evidence. +2 more reasons on the product page.